biguanides has been researched along with Diabetic Retinopathy in 9 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dynamic observation of certain ophthalmologic (visual acuity, macular thickness zone) and system functional parameters (lipid fractions content in serum) in long-term use of this medical drug in 20 patients with diabetes type 2 and DMO for 8 months." | 1.46 | [CHANGES OF LIFETIME MORPHOLOGICAL PARAMETERS OF THE RETINA ON THE BACKGROUND OF CORRECTION OF LIPID METABOLISM IN PATIENTSWITH TYPE 2 DIABETES MELLITUS]. ( Veselovskaya, NN, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veselovskaya, NN | 1 |
| MUETING, VD | 1 |
| Lunetta, M | 1 |
| Mughini, MT | 1 |
| Mughini, L | 1 |
| Rull, JA | 1 |
| Dies, H | 1 |
| Schulte, J | 1 |
| Gomez-Perez, FJ | 1 |
| Sanchez-Gochicoa, J | 1 |
| Figueroa, J | 1 |
| Lozano-Castañeda, O | 1 |
| Bloom, A | 1 |
| Vasiukova, EA | 1 |
| Margolis, MG | 1 |
| Debry, M | 1 |
| Oakley, WG | 1 |
| Raptis, S | 1 |
| Rothenbuchner, G | 1 |
| Pfeiffer, EF | 1 |
1 review available for biguanides and Diabetic Retinopathy
| Article | Year |
|---|---|
Some practical aspects of the management of diabetes.
Topics: Adult; Biguanides; Body Weight; Child; Contraceptives, Oral; Diabetes Complications; Diabetes Mellit | 1977 |
8 other studies available for biguanides and Diabetic Retinopathy
| Article | Year |
|---|---|
[CHANGES OF LIFETIME MORPHOLOGICAL PARAMETERS OF THE RETINA ON THE BACKGROUND OF CORRECTION OF LIPID METABOLISM IN PATIENTSWITH TYPE 2 DIABETES MELLITUS].
Topics: Aged; Biguanides; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fenofibrate; | 2017 |
[STUDIES ON THE EFFECT OF A BIGUANIDE ON THE PROTEIN METABOLISM AND THE DETOXICATION ACTIVITY OF THE LIVER IN DIABETES MELLITUS].
Topics: Biguanides; Blood Protein Electrophoresis; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retino | 1964 |
[Critical considerations on hyperlactacidemia induced by biguanides].
Topics: Biguanides; Creatinine; Diabetes Mellitus; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans | 1981 |
Long term treatment of asymptomatic diabetes.
Topics: Adult; Aged; Biguanides; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Female; Glu | 1979 |
[Complex treatment of patients with diabetes mellitus with diabetic retinopathy].
Topics: Aged; Anabolic Agents; Biguanides; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; | 1975 |
[Current data on the physiopathology of diabetes mellitus].
Topics: Biguanides; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Humans; Insulin; Sulfan | 1973 |
The management of diabetes over one-third of a century.
Topics: Biguanides; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Dietary Carbohydrates; | 1971 |
[Progress in the therapy of diabetes].
Topics: Adrenal Cortex Hormones; Adult; Aged; Aminocaproates; Animals; Biguanides; Blood Glucose; Child; Dia | 1971 |